Featured Research

from universities, journals, and other organizations

Coronary CTA: Non-invasive, Low Cost Alternative For 'Intermediate Risk' Patients

Date:
December 1, 2008
Source:
American Roentgen Ray Society
Summary:
Coronary CTA offers a low cost, non-invasive alternative to conventional angiography for evaluating patients who are suspected of having coronary artery disease; true even if the patients have calcified coronary artery plaques, according to a new study.

Coronary CTA offers a low cost, non-invasive alternative to conventional angiography for evaluating patients who are suspected of having coronary artery disease; true even if the patients have calcified coronary artery plaques, according to a study performed at the Thomas Jefferson University Hospital, Philadelphia, PA.

Related Articles


The study included 31 patients who had one or more calcified coronary artery plaques that were discovered during coronary CTA. Calcified plaques in the arteries were graded as small, moderate or large. Initially the accuracy rate of determining the degree of stenosis caused by the larger calcified plaques was 67%. The study is ongoing and “now with further experience, the accuracy rate of determining the degree of stenosis with larger plaques is 72%,” said David C. Levin, MD, lead author of the study.

“Patients who have calcified plaques in their coronary arteries can be evaluated accurately using coronary CTA. The procedure is non-invasive, cheaper and does not require hospitalization. Using coronary CTA you can look at a patient’s arteries from an infinite number of angles and look at cross sections of vessels. With conventional angiography, the patient usually is admitted to the hospital and the arteries are only visible from 7 to 10 different angles,” said Dr. Levin.

Coronary CTA is recommended for patients with an intermediate risk of coronary artery disease. “A good candidate is somebody who has an atypical chest pain pattern; chest pain that comes and goes during the day, night, exercise, rest etc. Family history, high cholesterol, diabetes, smoking and hypertension also play a big factor in the determining risk category,” said Dr. Levin.

This study appears in the December issue of the American Journal of Roentgenology.


Story Source:

The above story is based on materials provided by American Roentgen Ray Society. Note: Materials may be edited for content and length.


Journal Reference:

  1. Zhang, Shaoxiong, Levin, David C., Halpern, Ethan J., Fischman, David, Savage, Michael, Walinsky, Paul. Accuracy of MDCT in Assessing the Degree of Stenosis Caused by Calcified Coronary Artery Plaques. Am. J. Roentgenol., 2008; 191: 1676-1683 DOI: 10.2214/AJR.07.4026

Cite This Page:

American Roentgen Ray Society. "Coronary CTA: Non-invasive, Low Cost Alternative For 'Intermediate Risk' Patients." ScienceDaily. ScienceDaily, 1 December 2008. <www.sciencedaily.com/releases/2008/12/081201144549.htm>.
American Roentgen Ray Society. (2008, December 1). Coronary CTA: Non-invasive, Low Cost Alternative For 'Intermediate Risk' Patients. ScienceDaily. Retrieved November 28, 2014 from www.sciencedaily.com/releases/2008/12/081201144549.htm
American Roentgen Ray Society. "Coronary CTA: Non-invasive, Low Cost Alternative For 'Intermediate Risk' Patients." ScienceDaily. www.sciencedaily.com/releases/2008/12/081201144549.htm (accessed November 28, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Friday, November 28, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Ebola Leaves Orphans Alone in Sierra Leone

Ebola Leaves Orphans Alone in Sierra Leone

AFP (Nov. 27, 2014) — The Ebola epidemic sweeping Sierra Leone is having a profound effect on the country's children, many of whom have been left without any family members to support them. Duration: 01:02 Video provided by AFP
Powered by NewsLook.com
Experimental Ebola Vaccine Shows Promise In Human Trial

Experimental Ebola Vaccine Shows Promise In Human Trial

Newsy (Nov. 27, 2014) — A recent test of a prototype Ebola vaccine generated an immune response to the disease in subjects. Video provided by Newsy
Powered by NewsLook.com
Pet Dogs to Be Used in Anti-Ageing Trial

Pet Dogs to Be Used in Anti-Ageing Trial

Reuters - Innovations Video Online (Nov. 26, 2014) — Researchers in the United States are preparing to discover whether a drug commonly used in human organ transplants can extend the lifespan and health quality of pet dogs. Video provided by Reuters
Powered by NewsLook.com
Today's Prostheses Are More Capable Than Ever

Today's Prostheses Are More Capable Than Ever

Newsy (Nov. 26, 2014) — Advances in prosthetics are making replacement body parts stronger and more lifelike than they’ve ever been. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins